OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
In vivo emergence of cefiderocol and ceftazidime/avibactam cross-resistance in KPC-producing Klebsiella pneumoniae following ceftazidime/avibactam -based therapies
Stefano Amadesi, Alberto Amedeo, Matteo Rinaldi, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116372-116372
Closed Access | Times Cited: 5
Stefano Amadesi, Alberto Amedeo, Matteo Rinaldi, et al.
Diagnostic Microbiology and Infectious Disease (2024) Vol. 110, Iss. 1, pp. 116372-116372
Closed Access | Times Cited: 5
Showing 5 citing articles:
Whole genome sequencing characterization of the new KPC-245 variant-carrying Klebsiella pneumoniae strain isolated from a transplanted patient and resistant to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam
Claudia Vaiana, Roberta Vazzana, Salvatore Castelbuono, et al.
Journal of Global Antimicrobial Resistance (2025)
Open Access
Claudia Vaiana, Roberta Vazzana, Salvatore Castelbuono, et al.
Journal of Global Antimicrobial Resistance (2025)
Open Access
Genomic and molecular characterization of a ceftazidime-avibactam resistant Klebsiella pneumoniae strain isolated from a Chinese tertiary hospital
Yanye Tu, Hui Gao, Feng Wang, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Yanye Tu, Hui Gao, Feng Wang, et al.
BMC Microbiology (2025) Vol. 25, Iss. 1
Open Access
Mutations leading to ceftolozane/tazobactam and imipenem/cilastatin/relebactam resistance during in vivo exposure to ceftazidime/avibactam in Pseudomonas aeruginosa
Glenn J. Rapsinski, Alecia B. Rokes, Daria Van Tyne, et al.
Microbiology Spectrum (2025)
Open Access
Glenn J. Rapsinski, Alecia B. Rokes, Daria Van Tyne, et al.
Microbiology Spectrum (2025)
Open Access
Updates on the Activity, Efficacy and Emerging Mechanisms of Resistance to Cefiderocol
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 3
Gabriele Bianco, Matteo Boattini, Monica Cricca, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 12, pp. 14132-14153
Open Access | Times Cited: 3
Mutations Leading to Ceftolozane/Tazobactam and Imipenem/Cilastatin/Relebactam Resistance Duringin vivoexposure to Ceftazidime/Avibactam inPseudomonas aeruginosa
Glenn J. Rapsinski, Alecia B. Rokes, Daria Van Tyne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Glenn J. Rapsinski, Alecia B. Rokes, Daria Van Tyne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
